Cryoport Talks Compliance, Biopharma Expansion, and Brexit - Outsourcing-Pharma

November 13, 2018

Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Mark W. Sawicki, Ph.D., Chief Commercial officer...

Building an unbreakable Chain of Compliance™ - BioPharma Dealmakers

November 05, 2018

Regenerative medicine advanced therapies in the form of cell and gene therapies are breaking new ground, providing patients the potential of treatment, reversal or even cure of serious and...

Cryoport Tackles Market Needs with New NJ Facility - Contract Pharma

November 02, 2018

Cryoport recently unveiled its newest Global Logistics Center, based in Livingston, New Jersey with a ribbon-cutting ceremony attended by several of Cryoport’s clients, local dignitaries and...

Why the Cold Chain is Striking Hot - ASIA Outlook

October 29, 2018

Find out why the life science temperature-controlled space continues to grow apace in Asia Pacific and how supply chains can keep up with every-complex demands in a recent ASIA Outlook article by ...

Expert Opinion: The Latest Insight on the Life Sciences Supply Chain - ASIA Outlook

October 26, 2018

Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, offers his take on why the life sciences cold chain space continues to grow apace in Asia Pacific and how supply chains can keep up...

Be The Match BioTherapies, Cryoport Enter Agreement - Contract Pharma

October 04, 2018

Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry. The collaboration will support both...

Quality Systems for Regenerative Medicine Delivery; Basic Quality Requirements for Distribution - World Pharma Today

August 20, 2018

The emergence of regenerative medicine as a viable therapy class has created an urgency to review and improve upon the current quality systems distribution standards that are employed in support...

Cryoport, World Courier Ink Logistics Deal for Gene Therapies - Logistics for the Life Sciences

July 17, 2018

Cryoport, Inc. announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled products into its global network. This integrated platform...

The Chain of Compliance™ - Contract Pharma

June 14, 2018

Chain of Compliance™ is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W....

Exclusive interview with Cryoport CEO - Gasworld

April 10, 2018

Gasworld spoke to Jerry Shelton, Cryoport’s CEO, to find out how the latest regenerative medicines wouldn’t be possible without an often overlooked, yet extremely important component: logistics.s. 

Inside the Company Delivering the Next Generation of Cancer Therapies - Wired Magazine

March 05, 2018

When it comes to shipping CAR-T cells, there are many factors that come in to play in order for drug companies to successfully mitigate risk – that’s where Cryoport comes in. Check out a recent...

The Logistics Behind Personalized Medicine Delivery - Contract Pharma Article

February 21, 2018

Cryoport serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials to ensure a safe delivery, such as regenerative medicine, including immunotherapies, stem...

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment - Pharmaceutical Outsourcing

February 12, 2018

"Emerging technologies such as regenerative medicine will only increase the complexity of the logistics systems that need to be validated, especially as the requirements of the Drug Supply Chain...

CAR-T Supply Chain Logistics - Contract Pharma Article

November 06, 2017

"This past August, the FDA approved the first chimeric antigen receptor T cell (CAR-T) immunotherapy, Novartis’ Kymriah for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL). It...

Cryogenic Logistics Company Cryoport Grabs Contracts for Gilead, Novartis CAR-T Products - BioSpace Article

November 03, 2017

"In the world of developing and manufacturing cell-based therapeutics an approved medication for any indication is only part of the business plan. The other aspect is delivering the product to...

Intelligent Logistics: Key Considerations of Manufacturing Biologics

September 21, 2017

The pharmaceutical industry faces many challenges when manufacturing biologics in a commercial environment. Since manufacturing is being increasingly outsourced, cell bank production, maintenance...

Cold Chain Market and Technology Trends

September 06, 2017

The cold chain pharmaceutical market continues to be one garnering specific interest within the logistics space. New therapies such as regenerative therapies and gene therapies as well as a shift...

The Arrival of Quality by Design in Logistics

April 25, 2017

Quality by Design (QbD) is a concept that has become mainstream in the pharmaceutical manufacturing space in recent years. The QbD concept within cryogenic logistics cannot be implemented without...

Packaging, IT and Cold Chain Logistics Advances for the Future of Medicine and Clinical Trials

March 01, 2017

Many industry experts believe the most significant advancement for the future of medicine and clinical trials logistics is the realization that logistics has a direct and measurable scientific...

Risky Move

February 24, 2017

When transporting temperature-sensitive regenerative therapies, companies can mitigate risk by employing a Supply Chain Quality by Design (SC-QbD) process during clinical and commercial...

Biostorage: Closing the Loop in Biopharmaceutical Supply Chain Management

January 03, 2017 The complexity of shipping and storing temperature-sensitive biologics creates cold chain challenges. However, these risks can be mitigated when advanced packaging, data monitoring and biostorage...

IT and Logistics Solutions for Animal Vaccine Distribution

December 07, 2016

Animal vaccines are essential, not just because they can effectively prevent potentially serious diseases in animals, but also they can be beneficial to humans’ health. In an International Journal...

Cold Chain Planning: An Integrated Approach

December 03, 2016

CAR T-cell therapy, immunotherapy and other autologous cellular therapies require an integrated approach for their manufacture, shipment and storage. The need for integration is largely due to the...

Logistics Advancements and Trends in the Biopharma Industry

December 01, 2016

For successful commercial distribution, advanced cellular therapies require secure, well-designed cold chain management solutions based on effective packaging, informatics and logistics expertise....

Cold Chain Challenges Evolving With Industry

November 23, 2016

To ensure the safety and efficacy of inherently fragile regenerative medicines and other temperature-sensitive clinical trial therapeutics and biospecimens, the materials must be maintained within...